Twist Bioscience to Present at Upcoming Virtual Conferences

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the following upcoming virtual investor conferences:

• Truist Securities AI Symposium-Biotech & Tools Symposium on Tuesday, March 1; Applying the Power of AI to Synthetic Biology and Other Tools to Develop Therapeutics Panel at 9:00 a.m. Eastern Time.
• Cowen 42nd Annual Health Care Conference on Monday, March 7; fireside chat at 2:10 p.m. Eastern Time.
• Cowen 42nd Annual Health Care Conference on Monday, March 7; Synthetic Biology Enabling Technologies Panel at 10:30 a.m. Eastern Time.

The Cowen presentations will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the presentations will be archived for a period of 30 days following the conclusion of the live event.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005318/en/

For Twist Bioscience
Angela Bitting
SVP, Corporate Affairs
925- 202-6211
[email protected]

Source: Twist Bioscience Corporation

You May Also Be Interested In

• Piper Sandler Starts Twist Bioscience (TWST) at Overweight
• Dr. James Charasika Scholarship for Medical Students Opens 2026 Application Cycle for Undergraduate Pre-Medical Candidates Nationwide
• Dr. Jose Jacob Scholarship for Future Doctors Opens 2027 Applications to Support the Next Generation of Physicians Across the United States